128 related articles for article (PubMed ID: 31981)
21. Macrophages as cytotoxic effector cells.
Lohmann-Matthes ML; Lang H; Sun D
Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
[TBL] [Abstract][Full Text] [Related]
22. Bactericidal and tumoricidal activity of lymphokine-stimulated bone marrow macrophages.
Taskov HB
Folia Med (Plovdiv); 1980; 22(2):5-11. PubMed ID: 6777279
[No Abstract] [Full Text] [Related]
23. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
24. Macrophage activation for tumor cytotoxicity: reactivity of peritoneal and bone marrow macrophages.
Ruco LP; Meltzer MS; Leonard EJ; Tomisawa S
Adv Exp Med Biol; 1982; 141():85-97. PubMed ID: 7090936
[No Abstract] [Full Text] [Related]
25. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
Poste G; Kirsh R
Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
[TBL] [Abstract][Full Text] [Related]
26. In vitro modulation of macrophage tumoricidal activity: partial characterization of a macrophage-activating factor(s) in supernatants of NaIO4-treated peritoneal cells.
Weinberg JB; Hibbs JB
J Reticuloendothel Soc; 1979 Sep; 26(3):283-93. PubMed ID: 228037
[No Abstract] [Full Text] [Related]
27. Antitumor activity of macrophages grown in tumorous ascitic fluid.
Yamazaki M; Ikenami M; Yui S; Esumi-Kurisu M; Mizuno D
Gan; 1983 Feb; 74(1):155-61. PubMed ID: 6840434
[TBL] [Abstract][Full Text] [Related]
28. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
Nacy CA; Leonard EJ; Meltzer MS
J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the effects of endotoxin on macrophage tumor cell killing.
Weinberg JB; Chapman HA; Hibbs JB
J Immunol; 1978 Jul; 121(1):72-80. PubMed ID: 27559
[No Abstract] [Full Text] [Related]
30. Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines.
Meltzer MS; Ruco LP; Leonard EJ
Adv Exp Med Biol; 1979; 121B():381-98. PubMed ID: 397754
[No Abstract] [Full Text] [Related]
31. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes.
Ralph P
Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440
[No Abstract] [Full Text] [Related]
32. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
Ruco LP; Meltzer MS
J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
[TBL] [Abstract][Full Text] [Related]
33. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
34. Antileishmanial activities of macrophages from C3H/HeN and C3H/HeJ mice treated with Mycobacterium bovis strain BCG.
Pappas MG; Nacy CA
Cell Immunol; 1983 Sep; 80(2):217-22. PubMed ID: 6349826
[TBL] [Abstract][Full Text] [Related]
35. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
[TBL] [Abstract][Full Text] [Related]
36. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
Taffet SM; Pace JL; Russell SW
J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
[TBL] [Abstract][Full Text] [Related]
37. Genetic aspects of macrophage activation for tumor cytotoxicity.
Boraschi D
Adv Exp Med Biol; 1982; 141():119-28. PubMed ID: 7046393
[No Abstract] [Full Text] [Related]
38. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
39. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
Pace JL; Russell SW
J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of lymphokines from the EL-4 T cell line that activate macrophages for nonspecific tumor cytotoxicity.
Occhionero M; Leonard EJ; Meltzer MS
J Leukoc Biol; 1984 Apr; 35(4):405-14. PubMed ID: 6368713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
